NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-133-2016-0-US-01 FLT3-Specific Chimeric Antigen Receptors and Methods Using Same US 62/342,394 Abandoned
NCI E-150-2017-2-TT-15 Diagnostic Methods For T Cell Therapy TT National Stage TT/a/2017/00166 Abandoned
NCI E-282-2016-2-TT-19 Methods For Pre-conditioning Patients For Cell Therapy TT National Stage TT/A/2017/00165 Abandoned
NCI E-282-2016-2-UA-31 Methods For Pre-conditioning Patients For Cell Therapy UA National Stage 201712872 Abandoned
NCI E-150-2017-2-UA-27 Diagnostic Methods For T Cell Therapy UA National Stage a201712961 Abandoned
NCI E-282-2016-2-BR-01 Methods For Pre-conditioning Patients For Cell Therapy BR DIV BR122021025441-9 Abandoned
NCI E-282-2016-2-AU-01 Methods For Pre-conditioning Patients For Cell Therapy AU DIV 2022224754 Pending
NCI E-150-2017-2-BR-02 Diagnostic Methods For T Cell Therapy BR DIV BR122023022076-5 Pending
NCI E-282-2016-2-BR-02 Methods For Pre-conditioning Patients For Cell Therapy BR DIV BR122023017010-5 Pending
NCI E-150-2017-2-AU-01 Diagnostic Methods For T Cell Therapy AU DIV 2022231653 Pending
NCI E-150-2017-2-BR-04 Diagnostic Methods For T Cell Therapy BR DIV BR122024003420-4 Pending
NCI E-282-2016-2-BR-07 Methods For Pre-conditioning Patients For Cell Therapy BR National Stage BR112017025166-3 Pending
NCI E-150-2017-2-BR-01 Diagnostic Methods For T Cell Therapy BR DIV BR122021025400-1 Pending
NCI E-150-2017-2-IL-01 Diagnostic Methods For T Cell Therapy IL DIV 284172 Pending
NCI E-282-2016-2-GT-11 Methods For Pre-conditioning Patients For Cell Therapy GT National Stage A2017-000250 Abandoned
NCI E-282-2016-2-ID-23 Methods For Pre-conditioning Patients For Cell Therapy ID National Stage P00201709434 Abandoned
NCI E-150-2017-2-GT-07 Diagnostic Methods For T Cell Therapy GT National Stage A2017-000249 Abandoned
NIDDK E-011-2014-0-JP-09 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer JP National Stage 2016-534890 Abandoned
NCI E-150-2017-2-MY-10 Diagnostic Methods For T Cell Therapy MY National Stage PI2017001744 Abandoned
NCI E-150-2017-2-MX-01 Diagnostic Methods For T Cell Therapy MX DIV MX/a/2021/014047 Pending
NCI E-282-2016-2-MX-01 Methods For Pre-conditioning Patients For Cell Therapy MX DIV MX/a/2023/000049 Pending
NCI E-282-2016-2-MX-02 Methods For Pre-conditioning Patients For Cell Therapy MX DIV MX/a/2023/000050 Pending
NCI E-282-2016-2-MX-03 Methods For Pre-conditioning Patients For Cell Therapy MX DIV MX/a/2023/000051 Pending
NCI E-282-2016-2-MY-14 Methods For Pre-conditioning Patients For Cell Therapy MY National Stage PI 2017001745 Abandoned
NCI E-150-2017-2-JP-03 Diagnostic Methods For T Cell Therapy JP DIV 2024-129905 Pending
NCI E-150-2017-2-OA-23 Diagnostic Methods For T Cell Therapy OA National Stage 1201700454 Abandoned
NCI E-150-2017-2-EA-26 Diagnostic Methods For T Cell Therapy EA National Stage 201792642 Abandoned
NCI E-282-2016-2-AP-21 Methods For Pre-conditioning Patients For Cell Therapy AP National Stage AP/P/2017/010387 Abandoned
NCI E-150-2017-2-AP-17 Diagnostic Methods For T Cell Therapy AP National Stage AP/P/2017/010390 Abandoned
NCI E-088-2015-0-PCT-02 Extension of Replicative Lifespan in Diseases of Premature Aging Using P53 Isoforms PCT PCT PCT/US16/034821 Expired
NCI E-282-2016-2-EA-30 Methods For Pre-conditioning Patients For Cell Therapy EA National Stage 201792649 Abandoned
NCI E-282-2016-2-DO-10 Methods For Pre-conditioning Patients For Cell Therapy DO National Stage P2017-0271 Abandoned
NCI E-282-2016-2-CA-08 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY CA National Stage 2986798 Pending
NCI E-150-2017-2-CA-04 Diagnostic Methods For T Cell Therapy CA National Stage 2986793 Pending
NCI E-150-2017-2-DO-06 Diagnostic Methods For T Cell Therapy DO National Stage P2017-0272 Abandoned
NCI E-282-2016-2-CL-09 Methods For Pre-conditioning Patients For Cell Therapy CL National Stage 201703006 Abandoned
NCI E-150-2017-2-CL-05 Diagnostic Methods For T Cell Therapy CL National Stage 201703005 Abandoned
NIDDK E-742-2013-0-US-05 A3 Adenosine Receptor Agonists US National Stage 15/039,778 9963450 Issued PDF
NIDDK E-011-2014-0-US-08 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer US National Stage 15/039,781 Abandoned
NIDDK E-742-2013-0-EP-04 A3 Adenosine Receptor Agonists EP National Stage 14815994.0 Issued
NIDDK E-742-2013-0-GB-12 A3 Adenosine Receptor Agonists GB EP 14815994.0 Issued
NIDDK E-742-2013-0-ES-10 A3 Adenosine Receptor Agonists ES EP 14815994.0 Issued
NIDDK E-742-2013-0-IT-13 A3 Adenosine Receptor Agonists IT EP 14815994.0 Issued
NIDDK E-742-2013-0-DE-09 A3 Adenosine Receptor Agonists DE EP 14815994.0 Issued
NIDDK E-742-2013-0-FR-11 A3 Adenosine Receptor Agonists FR EP 14815994.0 Issued
NIAID E-170-2013-1-US-05 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION US National Stage 15/039,384 10246505 Issued PDF
NICHD E-552-2013-0-US-12 Adeno-Associated Virus Vectors for Treatment of Glycogen Storage Disease US National Stage 15/038,979 9644216 Issued PDF
NHLBI E-218-2016-0-US-01 Immunogens, Compositions, And Methods For Treating Dyslipidemia US 62/340,706 Abandoned
NCI E-257-2009-1-AU-14 Use Of IL-15 To Increase Thymic Output and to Treat Lymphopenia AU DIV 2016203362 Issued
NHLBI E-089-2013-1-US-01 Culture Medium For Stem Cell Differentiation US CIP 15/160,650 Abandoned